Newland Pharmaceutical Co.,Ltd.’s Net Profit Rose 30.7% in First Half of 2023

Newland Pharmaceutical Co.,Ltd. (新天地药业股份有限公司) (301277.SZ) reported a net profit of 93.2 million yuan in the first half of 2023, up 30.7% year-on-year.

Meanwhile, the company posted 334.1 million yuan in revenue, down 3.8% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 172.9 million yuan in total liabilities, with a liability-to-asset ratio of 11.1%.